vs
Side-by-side financial comparison of Ceribell, Inc. (CBLL) and Inuvo, Inc. (INUV). Click either name above to swap in a different company.
Ceribell, Inc. is the larger business by last-quarter revenue ($24.8M vs $14.3M, roughly 1.7× Inuvo, Inc.). Inuvo, Inc. runs the higher net margin — -4.2% vs -54.6%, a 50.4% gap on every dollar of revenue. Inuvo, Inc. produced more free cash flow last quarter ($-339.9K vs $-11.0M).
Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.
Inuvo, Inc. is a digital marketing technology firm that develops AI-powered advertising solutions. It offers intent-based audience targeting, performance marketing, and brand awareness services for retail, finance, and consumer goods clients, mainly operating across the North American market.
CBLL vs INUV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $24.8M | $14.3M |
| Net Profit | $-13.5M | $-593.9K |
| Gross Margin | 87.3% | 66.4% |
| Operating Margin | -58.9% | -8.5% |
| Net Margin | -54.6% | -4.2% |
| Revenue YoY | — | -45.6% |
| Net Profit YoY | — | -520.2% |
| EPS (diluted) | $-0.35 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $24.8M | $14.3M | ||
| Q3 25 | $22.6M | $22.6M | ||
| Q2 25 | $21.2M | $22.7M | ||
| Q1 25 | $20.5M | $26.7M | ||
| Q4 24 | — | $26.2M | ||
| Q3 24 | $17.2M | $22.4M | ||
| Q2 24 | — | $18.2M | ||
| Q1 24 | — | $17.0M |
| Q4 25 | $-13.5M | $-593.9K | ||
| Q3 25 | $-13.5M | $-1.7M | ||
| Q2 25 | $-13.6M | $-1.5M | ||
| Q1 25 | $-12.8M | $-1.3M | ||
| Q4 24 | — | $141.3K | ||
| Q3 24 | $-10.4M | $-2.0M | ||
| Q2 24 | — | $-1.7M | ||
| Q1 24 | — | $-2.1M |
| Q4 25 | 87.3% | 66.4% | ||
| Q3 25 | 88.3% | 73.4% | ||
| Q2 25 | 88.1% | 75.4% | ||
| Q1 25 | 87.9% | 79.0% | ||
| Q4 24 | — | 83.1% | ||
| Q3 24 | 87.3% | 88.4% | ||
| Q2 24 | — | 84.0% | ||
| Q1 24 | — | 87.7% |
| Q4 25 | -58.9% | -8.5% | ||
| Q3 25 | -64.8% | -7.4% | ||
| Q2 25 | -70.5% | -9.0% | ||
| Q1 25 | -69.3% | -6.6% | ||
| Q4 24 | — | 0.8% | ||
| Q3 24 | -57.8% | -8.7% | ||
| Q2 24 | — | -9.3% | ||
| Q1 24 | — | -12.3% |
| Q4 25 | -54.6% | -4.2% | ||
| Q3 25 | -59.6% | -7.7% | ||
| Q2 25 | -64.4% | -6.6% | ||
| Q1 25 | -62.4% | -4.7% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | -60.6% | -9.1% | ||
| Q2 24 | — | -9.6% | ||
| Q1 24 | — | -12.4% |
| Q4 25 | $-0.35 | — | ||
| Q3 25 | $-0.37 | $-0.12 | ||
| Q2 25 | $-0.38 | — | ||
| Q1 25 | $-0.36 | $-0.01 | ||
| Q4 24 | — | $0.14 | ||
| Q3 24 | $-1.85 | $-0.15 | ||
| Q2 24 | — | $-0.01 | ||
| Q1 24 | — | $-0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $159.3M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $155.3M | $10.0M |
| Total Assets | $195.8M | $24.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $159.3M | — | ||
| Q3 25 | $168.5M | — | ||
| Q2 25 | $177.4M | — | ||
| Q1 25 | $182.7M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $14.1M | — | ||
| Q2 24 | — | $2.0M | ||
| Q1 24 | — | $2.0M |
| Q4 25 | $155.3M | $10.0M | ||
| Q3 25 | $164.1M | $10.4M | ||
| Q2 25 | $172.2M | $12.1M | ||
| Q1 25 | $180.9M | $13.4M | ||
| Q4 24 | — | $13.5M | ||
| Q3 24 | $-136.0M | $12.4M | ||
| Q2 24 | — | $13.5M | ||
| Q1 24 | — | $15.1M |
| Q4 25 | $195.8M | $24.9M | ||
| Q3 25 | $199.5M | $29.9M | ||
| Q2 25 | $207.7M | $28.7M | ||
| Q1 25 | $213.5M | $31.7M | ||
| Q4 24 | — | $32.2M | ||
| Q3 24 | $47.1M | $29.0M | ||
| Q2 24 | — | $28.5M | ||
| Q1 24 | — | $29.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.8M | $21.0K |
| Free Cash FlowOCF − Capex | $-11.0M | $-339.9K |
| FCF MarginFCF / Revenue | -44.2% | -2.4% |
| Capex IntensityCapex / Revenue | 0.7% | 2.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-41.6M | $-3.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-10.8M | $21.0K | ||
| Q3 25 | $-11.1M | $-1.6M | ||
| Q2 25 | $-7.5M | $143.7K | ||
| Q1 25 | $-11.4M | $-366.9K | ||
| Q4 24 | — | $329.9K | ||
| Q3 24 | — | $1.1M | ||
| Q2 24 | — | $195.4K | ||
| Q1 24 | — | $-1.4M |
| Q4 25 | $-11.0M | $-339.9K | ||
| Q3 25 | $-11.5M | $-2.0M | ||
| Q2 25 | $-7.6M | $-263.1K | ||
| Q1 25 | $-11.6M | $-818.6K | ||
| Q4 24 | — | $-117.7K | ||
| Q3 24 | — | $584.0K | ||
| Q2 24 | — | $-266.3K | ||
| Q1 24 | — | $-1.8M |
| Q4 25 | -44.2% | -2.4% | ||
| Q3 25 | -50.8% | -8.7% | ||
| Q2 25 | -35.9% | -1.2% | ||
| Q1 25 | -56.4% | -3.1% | ||
| Q4 24 | — | -0.4% | ||
| Q3 24 | — | 2.6% | ||
| Q2 24 | — | -1.5% | ||
| Q1 24 | — | -10.7% |
| Q4 25 | 0.7% | 2.5% | ||
| Q3 25 | 1.6% | 1.7% | ||
| Q2 25 | 0.3% | 1.8% | ||
| Q1 25 | 0.7% | 1.7% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 2.1% | ||
| Q2 24 | — | 2.5% | ||
| Q1 24 | — | 2.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 2.33× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
INUV
Segment breakdown not available.
